2025 年12月7日,国家首批《商保创新药目录》正式公布:由卫材中国推出的阿尔茨海默病对因治疗药物仑卡奈单抗率先纳入《商保创新药目录》,这一新进展有助于让阿尔茨海默病患者“有药可治、有钱长治”,为患者留住记忆与尊严。依托于卫材集团强大的药品研发能力和卓越的产品力,以及叮当健康旗下DTP药房、线上线下一体化服务模式、专业药师服务能力,构建 “商保支付+24小时即时零售+专业药事服务+全生命周期...
Source Link2025 年12月7日,国家首批《商保创新药目录》正式公布:由卫材中国推出的阿尔茨海默病对因治疗药物仑卡奈单抗率先纳入《商保创新药目录》,这一新进展有助于让阿尔茨海默病患者“有药可治、有钱长治”,为患者留住记忆与尊严。依托于卫材集团强大的药品研发能力和卓越的产品力,以及叮当健康旗下DTP药房、线上线下一体化服务模式、专业药师服务能力,构建 “商保支付+24小时即时零售+专业药事服务+全生命周期...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.